Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Integrated Diagnostics Holdings Plc LSE:IDHC London Ordinary Share JE00BLKGSR75 ORD USD0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.01 1.67% 0.61 0.61 0.63 0.61 0.61 0.61 13,799 08:04:41
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 246.0 105.1 11.1 9.6 92

Integrated Diagnostics Share Discussion Threads

Showing 51 to 70 of 75 messages
Chat Pages: 3  2  1
DateSubjectAuthorDiscuss
06/12/2022
14:41
Finally - (and then I'll stop!) I notice that IDHC was included in Mark Simpson's 40 stock folio for income investing, back on October 26. Important to stress it's a highly diversified folio, so can afford some geographically specific headwinds - no doubt the case with IDHC.

hTTps://app.stockopedia.com/content/building-a-safer-income-portfolio-without-sacrificing-the-yield-956194?order=createdAt&sort=desc&;mode=threaded

He used this screen to generate the folio:

Market Cap > £150m.
TTM Earnings Yield, Rank in Market > 60%
TTM Dividend Yield, Rank in Industry Group > 60%
1-Year Rolling Dividend Yield, Rank in Industry Group > 60%
Net Gearing, including Pension < 50%

This portfolio is forecast to yield 7.2%, and 17 of the constituents have bought back shares within the last month. This is a very reasonable income from a (hopefully) well-protected portfolio.

Note: Though yielding above average for his folio, IDHC did not satisfy this last bit about director buy-backs, though as stated in previous posts, the CEO has a very high level of share ownership already!

brucie5
06/12/2022
13:13
hTTps://simplywall.st/stocks/gb/healthcare/lse-idhc/integrated-diagnostics-holdings-shares?blueprint=2191104&utm_medium=finance_user&;utm_campaign=conclusion&utm_source=yahoo

REWARDS
Trading at 75.8% below our estimate of its fair value

Earnings are forecast to grow 21.67% per year

Trading at good value compared to peers and industry

Analysts in good agreement that stock price will rise by 30.3%

RISK ANALYSIS
Dividend of 12.97% is not well covered by earnings or cash flows

High level of non-cash earnings

Profit margins (16.8%) are lower than last year (27.8%)

brucie5
06/12/2022
13:09
Hmm. Large buy reported here: wonder if it's the boss' investment proxy hoovering up off the floor again. She owns c. 26% of the company, I believe.

06-Dec-22 12:45:55 0.686 300,000 Buy* 0.672 0.70 205.80k

This link is quite interesting in showing who the buyers/sellers have been over last months.

hTTps://fintel.io/so/gb/idhc

brucie5
06/12/2022
08:39
I may have made a mistake by holding, nevermind adding here. But I do notice that the dividend was paid in full to small investors over the summer, at at 8.6% current, it's still an income stock. But also the ROE, ROC and operating margin are all top in their sector. So a nifty business, with severe currency headwinds.
brucie5
05/12/2022
12:32
Brucie5,
I also hold CAML, really like it. I don't perceive the liklihood of Russian invasion is particularly high right now. Th market seems to have priced that in.

ITV is interesting. Historically it has very high quality metrics and logic says that if it can navigate the changes in the way people view content then it should do really well but I certainly am no expert in te sector.

thorpematt
05/12/2022
11:43
Thanks Thorpematt. That's what I feared. Nevertheless, I have actually topped up this morning with some proceeds from the WEN bid. Not a huge amount, but it's sunk so much (40%) from my original buy in, while continuing to pay me good dividends that I feel able to take that risk - effectively buying down the EGP, in the prospect that the business will outlast this particular crisis. Probably at the riskiest end of my folio, which also includes CAML, where I also added. Main addition, btw, was to ITV, which I now see as very bullish with launch of ITVX and under the transformative leadership of Dame Carolyn McCall.

But wdik - NAI, obviously!

brucie5
05/12/2022
11:30
Brucie5,
I thought the TS was fine BUT no I don't hold any more and the reason for that is purely the currency issue.

I am talking EGP / GBP

I have not got time to post links but Egypt is struggling with the side effects of increased grain prices (I think they are one of the largest consumers of Ukrainian product). This is giving huge inflationary pressure to the EGP and recent devaluations of course affect IDHC's re-patraited earnings.

In the end a holding here, becomes more of a play on USD/GBP/EGP than it is a play on the company itself. WHich is a crying shame, because I really liek it but the EGP is currently something I am struggling to quantify in the mid-term.

thorpematt
05/12/2022
11:10
hTTps://uk.advfn.com/stock-market/london/integrated-diagnostics-IDHC/share-news/Integrated-Diagnostics-Holdings-PLC-3rd-Quarter-Re/89576886

Noone passed comment on these. Thorpematt, do you still hold?
Business on the ground appears to be doing well, though depreciation of the EGP.

3(rd) Quarter Results

Thursday, 17 November 2022

Integrated Diagnostics Holdings Plc reports sustained growth in non-Covid offering showcasing the fundamental strength and potential of the business

(Cairo and London) - Integrated Diagnostics Holdings ("IDH," "the Group," or "the Company"), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, released today its reviewed financial statements and operational performance for the nine-month period ended 30 September 2022, reporting revenue (compliant with IFRS) of EGP 2.8 billion. In line with the trend seen earlier in the year, IDH's conventional business (which includes IDH's full service roster excluding Covid-19-related tests) continued to showcase its underlying strength and potential, delivering a solid 14% year-on-year expansion, partially offsetting the expected decline in Covid-19-related(1) revenues for the nine-month period. Growth at IDH's conventional business (which made up 76% of total revenues) was supported by a solid 7% increase in test volumes, testament to the robust underlying demand for the Company's conventional test portfolio. Likewise, on a quarterly basis, conventional revenues expanded 17% year-on-year and 12% quarter-on-quarter in Q3 2022, making it the strongest three-month period performance ever recorded by the Group's conventional offering. Meanwhile, consolidated revenue for the third quarter stood at EGP 846 million, with the Group recording a net loss of EGP 36 million in Q3 2022. It is important to note that controlling for the losses resulting from transactions completed by the Company to secure the USD balance needed to fulfil its FY2021 dividend obligations to shareholders, the Group would have recorded a net profit of EGP 544 million in 9M 2022 and EGP 105 million in Q3 2022.

brucie5
19/10/2022
15:36
political risk

currency risk

post COVID reduction in forecasts overselling

execution risk (expansion plans)

recessionary risk (in particular for populations dependant on low cost grains to feed themselves against a backdrop of food inflation

That's about what I came up with. I hold BTW.

thorpematt
19/10/2022
10:35
Hi can someone explain to me why this is on such a low PE ratio please? On the face if it it doesn't make much sense
researchcentre123
07/9/2022
10:49
hTTps://uk.advfn.com/stock-market/london/integrated-diagnostics-IDHC/share-news/Integrated-Diagnostics-Holdings-PLC-IDC-terminatio/88991307

I may have misread it but...

brucie5
17/8/2022
15:02
Great article.
raleigh43
16/8/2022
18:49
Thanks for that correction-how did I not know! Still more impressive.
hTTps://www.lionessesofafrica.com/blog/2020/10/11/dr-hend-el-sherbini-a-leader-in-the-provision-of-best-in-class-diagnostic-services

brucie5
16/8/2022
14:28
CEO now owns almost 27%. He'll have to offer a bid soon.
;}

brucie5
06/8/2022
12:00
[...]

3.6m shares bought in total.

brucie5
05/8/2022
11:00
I had to blink, but there it is. 3.5m shares bought by the (PCA of) the CEO.


1. Details of PDMR / person closely associated with them
("PCA")
a) Name Hena Holdings Ltd
----------------------- --------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position / status PCA of Dr Hend El Sherbini, Chief Executive
Officer
----------------------- --------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- --------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name Integrated Diagnostics Holding plc
----------------------- --------------------------------------------
b) LEI 2138007JN9NUWKKTS790
----------------------- --------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description IDH Ordinary Shares of $0.25 each
of the financial
instrument
JE00BLKGSR75
Identification
Code
----------------------- --------------------------------------------
b) Nature of the Purchase of shares
transaction
----------------------- --------------------------------------------
c) Price(s) and Price(s) per share Volume(s)
volume(s) USD 0.9000 3,562,737
----------
----------------------- --------------------------------------------
d) Aggregated information

Aggregated volume
3,562,737
Price
USD 0.9000 per share

brucie5
04/8/2022
16:41
Some big Director buying and the price drops 5%?
essential
03/8/2022
12:24
Some very modest director buying.
brucie5
01/8/2022
10:34
Can't complain about dividend received, though.
brucie5
31/7/2022
07:49
I would have taken the extra 10% too if it was offered
johnthespacer
Chat Pages: 3  2  1
Your Recent History
LSE
IDHC
Integrated..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230130 08:22:33